RedHill Biopharma expands manufacturing capacity of Covid-19 drug candidate opaganib in US
RedHill Biopharma has forged partnerships with a couple of US-based manufacturers for large-scale manufacturing of opaganib, its Covid-19 drug candidate. The Israeli biopharma company said that the collaborations further progress its ongoing preparations to underpin potential emergency use applications for opaganib for the treatment of severe Covid-19 pneumonia, which are anticipated as early as Q1 […]